{
    "nctId": "NCT02062983",
    "briefTitle": "Early Predictor of Herceptin Cardio Toxicity in Breast Cancer Patients",
    "officialTitle": "Early Predictor of Herceptin Cardio Toxicity in Breast Cancer Patients",
    "overallStatus": "SUSPENDED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 50,
    "primaryOutcomeMeasure": "Estimate the incidence /of Herceptin induced heart failure in our population",
    "eligibilityCriteria": "Inclusion Criteria:\n\nBreast cancer cases with histopathology prove of invasive carcinoma with HER 2 over expression detected by immunochemical stain and/ or FISH.\n\nAge 18 to 80 years old. Patient with above criteria and eligible for Neu adjuvant/ adjuvant /metastatic( Trastuzumab) Herceptin therapy.\n\nNormal blood count, liver function test and kidney function.\n\nExclusion Criteria:\n\nAbnormal cardio vascular disease (ex. Heart Failure, Ischemic Heart Disease, post CABG) with EF\u226450.\n\nValvular abnormality with reduced ejection fraction (EF). Recent Myocardiac Infraction / Ischemia Pregnancy or Breast feeding",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}